Trial Profile

Phase 1 Vaccination Trial to Evaluate Safety, Tolerability and Immunogenicity of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 24 Aug 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MVA-BN WEV (Primary)
Indications Eastern equine encephalomyelitis; Equine encephalomyelitis; Venezuelan equine encephalomyelitis; Western equine encephalitis virus infections
Focus Adverse reactions; First in man
Sponsors Bavarian Nordic

19 Aug 2020 Status changed from active, no longer recruiting to completed.
08 Jun 2020 According to a Bavarian Nordic media release, this trial is funded by the United States Department of Defense's (DOD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense's (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical).
08 Jun 2020 Results presented in the Bavarian Nordic Media Release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com